Altesa BioSciences Enrolls First Patient in Phase 2b CARDINAL Clinical Trial Evaluating Vapendavir as Transformational Treatment for Patients with COPD Impacted by Rhinovirus ...

Altesa BioSciences, a clinical-stage pharmaceutical company dedicated to improving the lives of people with chronic lung diseases including COPD and asthma, today announced the enrollment of the first ...
American Lung Association

American Lung Association Launches National Research Study to Explore New Approach for Reducing COPD Flares

The American Lung Association today announced the launch of the COPD-OMA trial, a national clinical research effort conducted through its Airways Clinical Research Centers (ACRC). The study will ...
MedPage Today

In Patients with COPD and HFrEF, Are We Doing Enough, and Doing it Right?

Patients with HF, including those with concomitant COPD, benefit from treatment with BBs, and these drugs should be used to improve outcomes in these patients. However, not only are BBs not prescribed ...
European Medical Journal

Nebuliser Use Linked to Severe COPD

Nebuliser use in COPD is most common in severe disease with frequent exacerbations, high symptoms, and reduced lung function.
Medscape

Helping Your Patients Manage COPD in the Workplace

Your patients with chronic obstructive pulmonary disease (COPD) may need help not just coping with their condition but also managing it in their workplace. The symptoms of COPD, a lung and airway ...
The American Journal of Managed Care

Clinical Perspectives of Updated Management Strategies for COPD

AJMC®: The 2025 update of the GOLD Report (Global Initiative for Chronic Obstructive Lung Disease Global Strategy for Prevention, Diagnosis and Management of COPD) (GOLD 2025) recommends the ...

Nebuliser Use Linked To Severe Chronic Obstructive Pulmonary Disease: Study

Nebulisers are often used reactively, meaning they are introduced when symptoms become difficult to control rather than ...
Healio

Awareness of pulmonary hypertension in patients with COPD growing

Please provide your email address to receive an email when new articles are posted on . Pulmonary hypertension appears in 25% to 30% of patients with COPD. There are no approved therapies for patients ...
MedPage Today

How Do Patients with COPD Respond to Exacerbations?

—A new study finds that some patients are proactive (they seek immediate treatment), while others tough it out (wishing to avoid the ‘hassle’ or ‘inconvenience’). What can clinicians do to better ...
The American Journal of Managed Care

Study: Most Patients With COPD Remain Untreated Following Initial Diagnosis

Most patients with chronic obstructive pulmonary disease (COPD) remain untreated after diagnosis, leading to frequent exacerbations. After COPD diagnosis, prompt and effective single or dual ...
News Medical

Widespread inhaler misuse in COPD patients: Need for training

Chronic obstructive pulmonary disease (COPD) is a chronic lung condition characterized by loss of lung elasticity, which leads to dysfunctional gaseous exchange. COPD is the third leading cause of ...
Medscape

Is Pulmonary Rehab Right for Your Patient With COPD?

Leah Witt, MD: Hello. I'm Dr Leah Witt. Welcome back to season one of the Medscape inDiscussion chronic obstructive pulmonary disease (COPD) podcast series. Today, we're talking pulmonary rehab, the ...